News
A Multiple Sclerosis Disease Activity (MSDA) panel, based on Olink® Proximity Extension Assay (PEA) technology has been clinically validated as ...
Blood proteome profiling of 1400 patients presenting with 12 common types of cancer enabled machine learning derivation of a single ...
Mapping of the CSF proteome of autosomal dominant Alzheimer's disease (ADAD) reinforces its value for wider studies into Alzheimer'...
A large-scale proteomics study has identified high-performance protein signatures that can diagnose early lung cancer and predict long-...
UPPSALA, Sweden, July 12, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) today announced the introduction of Olink® Explore ...
A team from Stanford University identified protein biomarkers that significantly improve the estimation of M values for insulin resistance over ...
A newly developed a proteomics-based risk model for lung cancer has been shown to out-perform a currently used ...
UPPSALA, Sweden, June 28, 2023 -- Olink Holding AB (publ) (Nasdaq: OLK) today announced the availability of new findings into the ...
A large-scale protein biomarker discovery study used an extensive bioinformatics analysis to reveal hypoxia-mediated vascular proliferation as an ...
A longitudinal proteomics study that followed a population cohort of women over a 10 year period has identified protein biomarkers ...